Current
$917M
5-Year Average
$325M
All-Time High
$923M
All-Time Low
$48.6M
Market cap daily chart for Alto Neuroscience (ANRO)
Feb 2, 2024 – Jul 27, 2026 · 621 trading days
Market Cap growth chart for Alto Neuroscience (ANRO) from 2024 to 2026
Latest: +78.5%
Market Cap history table for Alto Neuroscience (ANRO) from 2024 to 2026
| 2026 | $917M | +78.5% | +$403M | ||
| 2025 | $514M | +393.5% | +$409M | ||
| 2024 | $104M | — | — |
- 2026$917M+78.5%
- 2025$514M+393.5%
- 2024$104M—
Market Cap values are taken from Alto Neuroscience's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's latest reported market cap is $739M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Alto Neuroscience (ANRO) market cap totalled $917M – surged 78.5% year-over-year.
Alto Neuroscience Market Cap by Year
Alto Neuroscience Market Cap 2026: $917M
Alto Neuroscience posted market cap of $917M in 2026, surged 78.5% from 2025. This figure represents the highest annual value in the available history.
Alto Neuroscience Market Cap 2025: $514M
In 2025, Alto Neuroscience reported market cap of $514M, surged 393.5% from 2024.
Alto Neuroscience Market Cap 2024: $104M
Alto Neuroscience market cap in 2024 was $104M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Market Cap
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest market cap
| $1.13T | |
| $640B | |
| $454B | |
| $379B | |
| $323B | |
| $221B | |
| $208B | |
| $203B |
- $1.13T
- $454B
- $323B
- $221B
- $203B
Frequently asked questions
Test yourself on ANRO
Market Cap — 10 rounds, every one of them ANRO against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.